Kardiyovasküler Akademi Derneği

Klinik Çalışmalar

  1. The Awareness, Efficacy, Safety and Time in Therapeutic Range of Warfarin in Turkish Population: WARFARIN-TR (Yayınlandı)
  2. Drug adherence in patients taking new oral anticoagulation therapy in Turkey: NOAC-TR (Yayınlandı)
  3. Patient Journey in Hospital with Heart Failure in Turkish Population: JOURNEY HF-TR (clinicaltrials.gov - NCT02487056,Yayınlandı)
  4. Normal Echocardiographic Measurements in A Turkish Population: The Healthy Heart ECHO-TR Trial (Yayınlandı)
  5. Türk Evaluation of Sexual Activity in Patients with Cardiovascular Disease in Turkey Hasta: EROS-TR (Tamamlandı)
  6. Cardiovascular Risk Unawareness is Common in Individuals Admitting to Cardiology Outpatient Clinics In Turkey: the CVSCORE-TR study (Yayınlandı)
  7. Medications and Lifestyles of Patients with Cardiovascular Risk Factors and/or Diseases In Turkish Population - MEDLIFE-TR (Tamamlandı)
  8. Diagnosis, Treatment and Prognosis of the Infective Endocarditis Patients in Tertiary Centers of Turkey: ENDOCARDITIS – TR (Tamamlandı)
  9. Prevalence and Clinical Profile of Patients with Myocardial Infarction with Non-obstructive Coronary Arteries in Turkey: A national multi-center, observational study: MINOCA-TR study (Yayınlandı)
  10. Demographic, Clinical Characteristics and Medications of Re-Hospitalized Patients for Acute Coronary Syndrome: A international multi-centre, observational study: BOOMERANG-ACS study (Yayınlandı)
  11. Bleeding risk in patients with acute coronary syndrome in a Turkish population: Results from the Turkish Acute Coronary Syndrome Registry: TACSER study (Yayınlandı)
  12. Patients in Turkey from RAMSES, NOAC-TR, WARFARIN-TR, AFTER Databases Comply with Phase 3 NOAC Trials? - PANAROMIC AF-TR (Tamamlandı)
  13. The Demographic, Clinical and Outcomes of Angiotensin Receptor-Neprilysin Inhibition in Turkish Population with Chronic Heart Failure and Reduced Ejection Fraction: ARNi-TR (Yayınlandı)
  14. Demographical and Clinical Profile of Patients with Left Ventricular Hypertrophy: LVH-TR (Tamamlandı)
  15. The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40% in Turkish Population: NEBIVOLOL-TR (Tamamlandı)
  16. Observational Study on Pneumococcal Vaccination Status and Awareness in Patients Applying to Cardiology Clinics in Turkey: VACCINE-TR (Tamamlandı)
  17. Secondary Prevention of Cardiovascular Diseases in Cardiology Outpatients: PREVENTION-TR (Devam etmektedir)

First slide